The therapeutic applications of and risks associated with acetaminophen use: A review and update

Journal of the American Dental Association

Volumn 142, Issue 1, 2011, Pages 38-44

  Guggenheimer, James ^a   Moore, Paul A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acetaminophen; Alcohol abuse; Analgesics; Drug; Drug labeling; Drugs pharmacology; Liver diseases; Pain; Prescriptions; U.s. Food and drug administration

Indexed keywords

EID: 79851475875     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2011.0026     Document Type: Review

References (43)

1. Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf 2005;28(3):227-240. (Pubitemid 40364889)
2. Nikles CJ, Yelland M, Del Mar C, Wilkinson D. The role of paracetamol in chronic pain: an evidenced-based approach. Am J Ther 2005;12(1):80-91. (Pubitemid 40516049)
3. Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol. Am J Ther 2005;12(l):56-66. (Pubitemid 40516047)
4. McNeil Consumer Healthcare Company Worldwide Consumer Pharmaceutical Intranet Site Content. History of Tylenol: early beginnings-McNeil, From Drug Store to Drug Development. "www.nancywest.net/pdfs/ McNeilConsumerHealthcareCompany.pdf". Accessed Nov. 19, 2010.
5. U.S. Food and Drug Administration. FDA drug safety communication: FDA recommends against the continued use of propoxyphene. "www.fda.gov/Drugs/ DrugSafety/ucm234338.htm". Accessed Nov. 30, 2010.
6. Wynn RL, Meiller TF, Crossley HL. Top 200 most prescribed drugs in 2008. In: Wynn RL, MeUler TF, Crossley HL, eds. Drug Information Handbook for Dentistry. 15th ed. Hudson, Ohio: LexiComp; 2009:2064-2065.
7. American Society of Health-System Pharmacists. AHFS Drug Information 2010. Bethesda, Md.: American Society of Health-System Pharmacists; 2010:2218-2225.
8. Acetaminophen clinical guidelines and studies, "www. tylenolprofessional.com/guidelines-and-studies.html". Accessed Sept. 10, 2010.
9. Hersh EV, Desjardins PJ, Trammel CL, Cooper SA. Nonopioid analgesics, nonsteroidal anti-inflammatory drugs, and antirheumatic and antigout drugs. In: Yagiela JA, Dowd FJ, Johnson BS, Mariotti AJ, Neidle EA, eds. Pharmacology and Therapeutics for Dentistry. 6th ed. St. Louis: Mosby Elsevier; 2011:346-348.
10. Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12(1):46-55. (Pubitemid 40516046)
11. Moore PA, Nahouraii HS, Zovko JG, Wisniewski SR. Dental therapeutic practice patterns in the U.S., part II: analgesics, corticosteroids, and antibiotics. Gen Dent 2006;54(3):201-207.
12. Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm B. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol 2002;54(3):320-326.
13. Woodcock J. A difficult balance: pain management, drug safety, and the FDA. N Engl J Med 2009;361(22):2105-2107.
14. Larson AM, Poison J, Fontana RJ, et al; Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42(6): 1364-1372.
15. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure (published correction appears in Am J Gastroenterol 2008;103[1]:255). Am J Gastroenterol 2007;102(11):2459-2463. (Pubitemid 47631759)
16. Lewis JH, Ahmed M, Shobassy A, Palese C. Drug-induced liver disease. Curr Opin Gastroenterol 2006;22(3):223-233. (Pubitemid 44090058)
17. Schilling A, Corey R, Leonard M, Eghtesad B. Acetaminophen: old drug, new warnings. Cleve Clin J Med 2010;77(1):19-27.
18. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Organspecific warnings: internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use-final monograph, final rule. Fed Regist 2009;74(81):19385-19409.
19. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002;22(2):145-155.
20. Dal Pan GJ. Acetaminophen: background and overview. Silver Spring, Md.: U.S. Food and Drug Administration, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research; 2009:75. "www.fda.gov/downloads/ AdvisoryCommittees/Committees%20MeetingMaterial a/Drugs/ DrugSafetyandRiskManagementAdvisoryCommittee/UCM175767. pdf". Accessed Nov. 29, 2010.
21. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006;354(7):731-739. (Pubitemid 43247143)
22. Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf 2007;3(K6):465-479. (Pubitemid 46873073)
23. Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 2002;95(9):609-619.
24. Hawton K, Simkin S, Deeks J, et al. UK legislation on analgesic packs: before and after study of long term effect on poisonings (published correction appears in BMJ 2004;329[7475]:1159). BMJ 2004;329(7474):1076.
25. Gunnell D, Hawton K, Murray V, et al. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: are restrictions on availability justified? J Epidemiol Community Health 1997;51(2):175-179.
26. Watkins PB, Kaplowitz N, Slattery JT, et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296(1):87-93.
27. Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008;359(3):285-292.
28. Teoh NC, Farrell GC. Liver disease caused by drugs. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 8th ed. Philadelphia: Saunders; 2006:1822-1825.
29. Martin P, Rosen HR. Liver transplantation. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 8th ed. Philadelphia: Saunders; 2006:2044.
30. Merry AF, Gibbs RD, Edwards J, et al. Combined acetaminophen and Ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial. Br J Anaesth 2010;104(1):80-88.
31. Akural EI, Järvimäki V, Länsineva A, Niinimaa A, Alahuhta S. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial. Clin Ther 2009;31(3):560-568.
32. Weil K, Hooper L, Afzal Z, et al. Paracetamol for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev 2007;(3):CD004487.
33. Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther 2005;12(2): 133-141.
34. Nguyen GC, Sam J, Thuluvath PJ. Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis. Hepatology 2008; 48(4):1336-1341.
35. Kuffner EK, Green JL, Bogdan GM, et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients: a multicenter randomized study. BMC Med 2007;5:13.
36. Seifert CF, Anderson DC. Acetaminophen usage patterns and concentrations of glutathione and gamma-glutamyl transferase in alcoholic subjects. Pharmacotherapy 2007;27(11):1473-1482. (Pubitemid 350060202)
37. Dart RC, Kuffner EK, Rumack BH. Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: a systematic review. Am J Ther 2000;7(2):123-134.
38. Waring WS, Stephen AF, Malkowska AM, Robinson OD. Acute ethanol coingestion confers a lower risk of hepatotoxicity after deliberate acetaminophen overdose. Acad Emerg Med 2008;15(1):54-58.
39. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther 2007;29(suppl):2477-2497. (Pubitemid 350299458)
40. Tsukamoto H. Conceptual importance of identifying alcoholic liver disease as a lifestyle disease. J Gastroenterol 2007;42(8): 503-609.
41. Kotlyar DS, Campbell MS, Reddy KR. Recurrence of diseases following orthotopic liver transplantation (published correction appears in Am J Gastroenterol 2006;101[8]:1944). Am J Gastroenterol 2006;101(6):1370-1378. (Pubitemid 43830007)
42. Burra P, Senzolo M, Adam R, et al; ELITA; ELTR Liver Transplant Centers. Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry). Am J Transplant 2010;10(1):138-148.
43. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009:24(7):783-788.